纳米炭示踪剂不同注射时间影响食管胃结合部腺癌新辅助放化疗联合手术切除淋巴结检出效果的前瞻性研究

Influence of different injection time of carbon nanoparticle tracer on the acquisition of lymph nodes in adenocarcinoma of esophagogastric junction treated by neoadjuvant chemoradio-therapy combined with surgical resection: a prospective study

  • 摘要:
    目的 探讨纳米炭示踪剂不同注射时间对食管胃结合部腺癌(AEG)行新辅助放化疗(nCRT)联合手术切除淋巴结检出效果的影响。
    方法 采用前瞻性随机对照研究方法。选取2020年3月至2021年3月河北医科大学第四医院收治的120例行nCRT+手术切除AEG患者的临床病理资料,按照随机数字表法将患者分为两组。患者行nCRT前24 h,经内镜注射纳米炭示踪剂设为试验组;患者行手术切除前24 h,经内镜注射纳米炭示踪剂设为对照组。所有患者采用统一nCRT方案,联合行胃癌D2根治术。观察指标:(1)入组患者分组情况。(2)手术和术后病理学检查情况。(3)术后并发症及治疗情况。正态分布的计量资料以x±s表示,组间比较采用独立样本t检验。偏态分布的计量资料以MQ1,Q3)表示,组间比较采用Mann‑Whitney U检验。计数资料以绝对数表示,组间比较采用χ²检验。等级资料采用非参数秩和检验。
    结果 (1)入组患者分组情况。筛选出符合条件的患者120例,男85例,女35例;年龄为(60±9)岁。120例患者中,试验组和对照组各60例。(2)手术和术后病理学检查情况。两组患者均顺利行胃癌D2根治术,均为R0切除。试验组患者淋巴结获检数目,淋巴结染色数目,染色淋巴结转移数目,微小淋巴结数目,下纵隔区淋巴结数目,下纵隔区淋巴结染色数目,术后病理学N分期(N0期、N1期、N2期、N3a期)分别为(40.6±13.9)枚,(20.1±7.7)枚,1.0(0,3.0)枚,(8.1±2.8)枚,(3.7±1.3)枚,2.0(1.0,2.0)枚,18、13、23、6例;对照组患者上述指标分别为(30.4±8.3)枚,(12.7±3.5)枚,0(0,1.0)枚,(6.2±2.0)枚,(2.4±1.2)枚,1.0(0,1.0)枚,23、21、15、1例;两组患者上述指标比较,差异均有统计学意义(t=-5.01、6.85,Z=-3.78,t=-4.04、-5.57、Z=-5.48、-2.12,P<0.05)。(3)术后并发症及治疗情况。试验组和对照组患者发生术后并发症分别为5例和7例,两组比较,差异无统计学意义(χ²=0.37,P>0.05)。发生术后并发症患者经对症治疗后均好转。
    结论 与行手术切除前24 h注射纳米炭示踪剂比较,行nCRT前24 h注射纳米炭示踪剂可提高AEG患者行nCRT联合手术切除淋巴结获检效果。

     

    Abstract:
    Objective To investigate the influence of different injection time of carbon nanoparticle tracer on the acquisition of lymph nodes in adenocarcinoma of esophagogastric junc-tion (AEG) treated by neoadjuvant chemoradiotherapy (nCRT) combined with surgical resection.
    Methods The prospective randomized controlled study was conducted. The clinicopathological data of 120 AEG patients who were treated by nCRT combined with surgical resection in the Fourth Hospital of Hebei Medical University from March 2020 to March 2021 were selected. Based on random number table, patients were allocated into two groups. Patients undergoing endoscopic injection of carbon nanoparticle tracer 24 hours before nCRT were allocated into the experiment group, and patients undergoing endoscopic injection of carbon nanoparticle tracer 24 hours before surgical resection were allocated into the control group. All patients received the same plan of nCRT combined with D2 radical gastrectomy. Observation indicators: (1) grouping situations of the enrolled patients; (2) surgical and postoperative pathological situations; (3) postoperative complications and treatment. Measurement data with normal distribution were represented as Mean±SD, and comparison between groups was analyzed using the independent sample t test. Measurement date with skewed distribution were represented as M(Q1,Q3), and comparison between groups was conducted using the Mann‑Whitney U test. Count data were described as absolute numbers, and comparison between groups was analyzed using the chi‑square test. Comparison of ordinal data was analyzed using the non‑parameter rank sum test.
    Results (1) Grouping situations of the enrolled patients. A total of 120 patients were selected for eligibility. There were 85 males and 35 females, aged (60±9)years. There were 60 patients in the experiment group and 60 patients in the control group, respectively. (2) Surgical and postoperative pathological situations. Patients in the two groups underwent D2 radical gastrectomy successfully, with R0 resection. The number of lymph nodes harvest, the number of lymph nodes stained, the number of metastatic lymph nodes stained, the number of micro lymph nodes, the number of inferior mediastinal lymph nodes, the number of inferior mediastinal lymph nodes stained, cases in postoperative pathological stage N0, stage N1, stage N2, stage N3a were 40.6±13.9,20.1±7.7, 1.0(0,3.0), 8.1±2.8, 3.7±1.3, 2.0(1.0,2.0), 18, 13, 23, 6 in patients of the experiment group, respectively. The above indicators were 30.4±8.3, 12.7±3.5, 0(0,1.0), 6.2±2.0, 2.4±1.2, 1.0(0,1.0), 23, 21, 15, 1 in patients of the control group, respectively. There were significant differences in the above indicators between the two groups (t=-5.01, 6.85, Z=-3.78, t=-4.04, -5.57, Z=-5.48, -2.12, P<0.05). (3) Postoperative complications and treatment. There were 5 cases of the experiment group and 7 cases of the control group with postoperative complications, showing no significant difference between the two groups (χ²=0.37, P>0.05). The patients with postoperative complications were improved after symptomatic treatment.
    Conclusion Compared with injection of carbon nanoparticle tracer 24 hours before surgical resection, injection of carbon nanoparticle tracer 24 hours before nCRT can improve the acquisition of lymph nodes in AEG treated by nCRT combined with surgical resection.

     

/

返回文章
返回